Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation by Justin P. Rosenheck, Kashika Goyal, Tara Fallah, Pamela Burcham, Kukbin Choi, Matthew Henn, Elie Homsy, Scott Visovatti, Veronica Franco

Subjects: “…Pulmonary Arterial Hypertension…”
Get full text

The 50‐year‐old pulmonary artery catheter: the tale of a foretold death? by Guillaume Leurent, Clément Delmas, Vincent Auffret, Eric Bonnefoy, Etienne Puymirat, FranÇois Roubille

Get full text

Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency by Mark A. Colantonio, Sanjana Aggarwal, Himanshu Deshwal

Subjects: Get full text

Pulmonary Hypertension due to a Pulmonary Artery Leiomyosarcoma: A Case Report by Seyyed Hassan Adeli, Bardia Nemati, Mahboubeh Jandaghi, Mohammad Mahdi Riahi, Fatemeh Hosseinzadeh, Fatemeh Salarvand

“…Background. Primary pulmonary artery sarcomas are very rare and their histologic type, called leiomyosarcoma, is even rarer. …”
Get full text

Investigation of the Pulmonary Artery Hypertension Using an Ad Hoc OpenFOAM CFD Solver by Francesco Duronio, Paola Marchetti

Subjects: Get full text

Rare Case of a Calcified Catheter-Related Sheath Embolizing to the Right Pulmonary Artery by Lee K. Rousslang, Jonathan R. Wood

“…We report the case of catheter-related sheath embolization to the right pulmonary artery in a child, as confirmed on CT.…”
Get full text

Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension by Liu H, Liu S, Ma P, Ma L, Liu Y, Zhao F, Zhou R

“…Furthermore, the concentrations of aloperine in the lungs of the NLCs group were 1.79, 3.78, and 2.30 times higher than those in the solution group at three time points (0.25 h, 1.5 h, 4 h), suggesting that NLCs can increase the accumulation of aloperine in the lungs.Conclusion: Our findings suggest that NLCs loaded with aloperine could offer a promising strategy for the treatment of pulmonary arterial hypertension.Keywords: aloperine, nanostructured lipid carrier, aerosol inhalation, pharmacokinetics…”
Get full text

Extranodal Rosai–Dorfman Disease Presenting as a Mediastinal Mass with Pulmonary Artery Invasion by Andrew R. Orr, Daniel Lefler, C. Deshpande, Pallavi Kumar

“…While case reports of extranodal involvement in nearly every organ system exist, documented instances of mediastinal and pulmonary artery involvement are particularly rare. This study describes the case of a middle-aged woman presenting with new onset right heart failure who was found to have extranodal RDD in the form of a large mediastinal mass with invasion and occlusion of the main pulmonary arteries.…”
Get full text

Canadian Cardiovascular Society and Canadian Thoracic Society Position Statement on Pulmonary Arterial Hypertension by David Langleben, Stephen Archer, John Granton, Andrew M Hirsch, Robert D Levy, Sanjay Mehta, Evangelos Michelakis, Duncan J Stewart

“…The Canadian Cardiovascular Society and the Canadian Thoracic Society requested a position statement on pulmonary arterial hypertension from leading Canadian experts. …”
Get full text

Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension by Bodil Ivarsson, Björn Ekmehag, Trygve Sjöberg

“…Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal, noncurable, but treatable diseases that strongly affect the patients. …”
Get full text

CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats by Hua Guan, Xiaofeng Yang, Tao Shi, Yongjian Zhang, Aoqi Xiang, Yongxin Li

“…The present study is aimed at investigating the molecular mechanism of C1q/TNF-related protein 9 (CTRP9) and providing a new perspective in arteriovenous shunt-induced pulmonary arterial hypertension (PAH). PAH was established by an arteriovenous shunt placement performed in rats. …”
Get full text

Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions by Ioan Teodor Dragoi, Ciprian Rezus, Alexandra Maria Burlui, Ioana Bratoiu, Elena Rezus

Subjects: Get full text

Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension by Richard Channick, MD, Sarah Medrek, MD, Marion Delcroix, MD, Sean Gaine, MD, Pavel Jansa, MD, PhD, Irene Lang, MD, Vallerie McLaughlin, MD, Sanjay Mehta, MD, Tomas Pulido, MD, Bhagavatula Sastry, MD, Rogerio Souza, MD, PhD, Adam Torbicki, MD, Carol Zhao, MS, Paul Strachan, MD, Peter Agron, PhD, Joseph Yen, PhD, Olivier Sitbon, MD, PhD

Subjects: “…Pulmonary arterial hypertension…”
Get full text

The Association of the Pulmonary Artery Pulsatility Index and Right Ventricular Function after Cardiac Surgery by Johnny Wei, Abigail Kee, Rachel Dukes, Jack Franke, Vincent Leonardo, Brigid C. Flynn

“…Background. The pulmonary artery pulsatility index (PAPi) has been shown to correlate with right ventricular (RV) failure in patients with cardiac disease. …”
Get full text

In Situ Thrombosis of Small Pulmonary Arteries in Pulmonary Hypertension Developing after Chemotherapy for Malignancy by Kay Maeda, Yoshikatsu Saiki, Shigeo Yamaki

“…Autopsy showed complete occlusion of the peripheral small pulmonary arteries and veins by thrombi. These results demonstrate that in situ thrombosis in the small pulmonary arteries could cause pulmonary hypertension after chemotherapy.…”
Get full text

Bilateral Ductal Stenting for Discontinuity of the Pulmonary Artery via the Femoral and Carotid Arteries in an Infant by Osman Baspinar, Derya Aydin Sahin

“…We present a case of bilateral ductal stenting via both the femoral and carotid arteries in a little child with tetralogy of Fallot with pulmonary atresia and a nonconfluent pulmonary artery and bilateral ductus arteriosus.…”
Get full text

Effect of Transcriptional Regulator ID3 on Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia by Vincent Avecilla

“…Pulmonary arterial hypertension (PAH) can be discovered in patients who have a loss of function mutation of activin A receptor-like type 1 (ACVRL1) gene, a bone morphogenetic protein (BMP) type 1 receptor. …”
Get full text

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study by Su-Gang Gong, Lan Wang, Bigyan Pudasaini, Ping Yuan, Rong Jiang, Qin-Hua Zhao, Jing He, Rui Zhang, Wen-hui Wu, Jin-Ming Liu, Cai-cun Zhou

“…Background and objective: Two endothelin receptor antagonists (ETRAs), bosentan and ambrisentan, are approved for patients with pulmonary arterial hypertension (PAH). However, there is little information about the transition strategy between these two ETRAs. …”
Get full text

The Impact of a Pulmonary-Artery-Catheter-Based Protocol on Fluid and Catecholamine Administration in Early Sepsis by Carina Bethlehem, Frouwke M. Groenwold, Hanneke Buter, W. Peter Kingma, Michael A. Kuiper, Fellery de Lange, Paul Elbers, Henk Groen, Eric N. van Roon, E. Christiaan Boerma

“…Objective. The pulmonary artery catheter (PAC) remains topic of debate. …”
Get full text

Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertension by Heather L. Clark, Daniel Lachant, Allison N. Light, Deborah Haight, Samia Lopia, Nigel Mackman, R. James White

Subjects: “…pulmonary arterial hypertension…”
Get full text